US Stocks

PATH Stock Rises 1.5% in Pre-Market Trading on May 5, 2026

Key Points

UiPath PATH stock gains 1.5% to $10.83 in pre-market trading.

Meyka AI rates PATH with B+ grade and Buy recommendation.

Vanguard increases stake to 9.18% signaling institutional confidence.

Q1 2027 earnings report scheduled for May 28, 2026.

Be the first to rate this article

UiPath Inc. (PATH) is climbing in pre-market trading on May 5, 2026, gaining 1.5% to reach $10.83 per share on the NYSE. The robotic process automation leader shows resilience despite a challenging year, with its stock down 34% year-to-date. However, recent institutional buying and strong fundamentals are catching investor attention. Meyka AI’s analysis reveals a B+ grade for PATH stock, supported by solid earnings growth and analyst consensus favoring the automation platform. With earnings scheduled for May 28, traders are positioning ahead of the report.

PATH Stock Performance and Market Sentiment

UiPath’s PATH stock opened at $10.68 with a day range of $10.63 to $11.06, showing modest volatility in early trading. The 30.6 million shares traded so far represent typical volume activity. Year-to-date, PATH stock has declined significantly, but the recent 1.5% gain signals potential stabilization.

Vanguard Group recently increased its stake by 2.5%, now holding 9.18% of UiPath worth $805 million. This institutional confidence matters. The stock trades at a P/E ratio of 20.83, reasonable for a software infrastructure company with growth potential. Track PATH on Meyka for real-time updates on institutional activity and price movements.

Financial Metrics and Valuation Analysis

UiPath demonstrates solid financial health with a market cap of $5.83 billion and strong cash position. The company’s net profit margin of 17.5% reflects efficient operations, while gross margin of 83.2% shows pricing power in its automation platform.

Key metrics reveal balanced growth: EPS of $0.52 with 18% net income growth year-over-year. The price-to-sales ratio of 3.63 sits below historical averages, suggesting reasonable valuation. Free cash flow per share stands at $0.66, supporting the company’s ability to invest in R&D and return value to shareholders. Debt levels remain minimal with a debt-to-equity ratio of 3.4%, providing financial flexibility.

Analyst Consensus and Meyka AI Grade

Wall Street maintains a cautiously optimistic stance on PATH stock. The analyst consensus shows 12 Hold ratings, 2 Buy ratings, and 1 Sell rating, reflecting divided opinion on near-term direction. Meyka AI rates PATH with a grade of B+, suggesting a buy opportunity for patient investors.

This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The company’s strong ROA of 8.9% and ROE of 15.3% support the positive assessment. Meyka AI’s forecast model projects yearly price targets of $14.15, implying 30% upside from current levels. Forecasts are model-based projections and not guarantees.

Technical Setup and Trading Activity

Technical indicators show mixed signals for PATH stock. The RSI of 52.29 sits near neutral territory, neither overbought nor oversold. The CCI reading of 102 suggests some overbought conditions, while the MACD histogram of 0.07 indicates weakening momentum.

Volume activity remains steady at 30.6 million shares, slightly below the 31.7 million average. The stock trades within Bollinger Bands, with support at $9.69 and resistance at $11.15. The Money Flow Index of 66.42 shows strong institutional accumulation. Earnings announcement on May 28 could trigger significant price movement, making this a critical watch date for PATH stock traders.

Final Thoughts

UiPath Inc. (PATH) presents a mixed but intriguing picture for investors on May 5, 2026. The stock’s 1.5% pre-market gain reflects growing institutional interest, evidenced by Vanguard’s recent stake increase. While PATH stock remains down significantly year-to-date, the company’s strong fundamentals, B+ Meyka grade, and reasonable valuation suggest potential recovery. The upcoming May 28 earnings report will be pivotal. Investors should monitor analyst coverage and technical levels closely. These grades are not guaranteed and we are not financial advisors. Do your own research before making investment decisions.

FAQs

What is the current PATH stock price and today’s movement?

PATH trades at $10.83 in pre-market on May 5, 2026, up 1.5% ($0.16). Day range: $10.63–$11.06. Year-to-date down 34%, but recent institutional buying suggests stabilization.

What is Meyka AI’s rating for UiPath Inc. stock?

Meyka AI rates PATH B+ with a Buy recommendation, considering S&P 500 benchmarks and sector performance. The forecast model projects $14.15 yearly, implying 30% upside potential.

Why did Vanguard increase its UiPath stake?

Vanguard increased PATH holdings by 2.5% in Q4 to 9.18% ($805 million), signaling confidence in UiPath’s long-term prospects and automation market position.

When is UiPath’s next earnings report?

UiPath announces Q1 2027 earnings on May 28, 2026 at 4:00 PM ET. This critical date could significantly impact PATH stock price for traders and investors.

What are PATH stock’s key financial metrics?

PATH shows strong fundamentals: 17.5% net margin, 83.2% gross margin, $0.52 EPS (18% growth), 3.4% debt-to-equity ratio, $5.83 billion market cap, 538 million shares outstanding.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)